STOCK TITAN

[Form 4] Enterprise Bancorp Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

United States Antimony Corporation (NYSE American: UAMY) has secured a secondary listing on the newly formed NYSE Texas Exchange. On June 27, 2025, the Exchange formally approved the Company’s application, and trading of UAMY shares on NYSE Texas is expected to begin Tuesday, July 1, 2025. The Company will retain its primary listing on NYSE American and continue to trade under the ticker “UAMY” on both venues. A press release announcing the dual-listing is filed as Exhibit 99.1 and incorporated into this Form 8-K/A under Item 8.01. No other operational or financial information was disclosed, and the filing is furnished—not filed—for Exchange Act liability purposes.

United States Antimony Corporation (NYSE American: UAMY) ha ottenuto una quotazione secondaria sulla neocostituita NYSE Texas Exchange. Il 27 giugno 2025, la Borsa ha approvato formalmente la domanda della Società e la negoziazione delle azioni UAMY su NYSE Texas è prevista per martedì 1 luglio 2025. La Società manterrà la sua quotazione primaria su NYSE American e continuerà a essere negoziata con il simbolo “UAMY” su entrambe le piattaforme. Un comunicato stampa che annuncia la doppia quotazione è allegato come Exhibit 99.1 e integrato in questo modulo 8-K/A sotto la voce 8.01. Non sono state divulgate altre informazioni operative o finanziarie; la documentazione è fornita e non depositata ai fini della responsabilità ai sensi dell'Exchange Act.

United States Antimony Corporation (NYSE American: UAMY) ha asegurado una cotización secundaria en la recién creada Bolsa NYSE Texas Exchange. El 27 de junio de 2025, la Bolsa aprobó formalmente la solicitud de la Compañía y se espera que la negociación de las acciones UAMY en NYSE Texas comience el martes 1 de julio de 2025. La Compañía mantendrá su cotización primaria en NYSE American y continuará operando bajo el símbolo “UAMY” en ambos mercados. Un comunicado de prensa que anuncia la doble cotización se presenta como Exhibit 99.1 e incorporado en este Formulario 8-K/A bajo el ítem 8.01. No se divulgaron otras informaciones operativas ni financieras; la presentación se proporciona y no se registra para fines de responsabilidad bajo la Exchange Act.

United States Antimony Corporation (NYSE American: UAMY)는 새로 설립된 NYSE Texas Exchange에 2차 상장을 확보했습니다. 2025년 6월 27일, 거래소는 회사의 신청을 공식 승인했으며, UAMY 주식의 NYSE Texas 거래는 2025년 7월 1일 화요일에 시작될 예정입니다. 회사는 NYSE American에서의 주 상장을 유지하며 두 거래소 모두에서 “UAMY” 티커로 계속 거래될 것입니다. 이중 상장을 알리는 보도자료는 Exhibit 99.1로 제출되어 본 8-K/A 양식의 항목 8.01에 통합되어 있습니다. 추가적인 운영 또는 재무 정보는 공개되지 않았으며, 이 제출은 Exchange Act 책임 목적을 위한 제공(furnished)이며 제출(filed)은 아닙니다.

United States Antimony Corporation (NYSE American : UAMY) a obtenu une cotation secondaire sur la nouvelle Bourse NYSE Texas Exchange. Le 27 juin 2025, la Bourse a officiellement approuvé la demande de la Société, et la négociation des actions UAMY sur NYSE Texas devrait débuter le mardi 1er juillet 2025. La Société conservera sa cotation principale sur NYSE American et continuera à être négociée sous le symbole « UAMY » sur les deux places. Un communiqué de presse annonçant la double cotation est déposé en tant qu’Exhibit 99.1 et intégré à ce formulaire 8-K/A sous l’Item 8.01. Aucune autre information opérationnelle ou financière n’a été divulguée, et ce dépôt est fourni (furnished) — non déposé (filed) — aux fins de responsabilité au titre de l’Exchange Act.

United States Antimony Corporation (NYSE American: UAMY) hat eine Zweitnotierung an der neu gegründeten NYSE Texas Exchange erhalten. Am 27. Juni 2025 genehmigte die Börse offiziell den Antrag des Unternehmens, und der Handel mit UAMY-Aktien an der NYSE Texas soll am Dienstag, den 1. Juli 2025 beginnen. Das Unternehmen behält seine Hauptnotierung an der NYSE American bei und wird unter dem Tickersymbol „UAMY“ an beiden Börsen gehandelt. Eine Pressemitteilung zur Bekanntgabe der Doppelnotierung ist als Exhibit 99.1 eingereicht und in dieses Formular 8-K/A unter Punkt 8.01 aufgenommen. Weitere operative oder finanzielle Informationen wurden nicht offengelegt; die Einreichung erfolgt zur Haftungszwecken gemäß Exchange Act als „furnished“, nicht als „filed“.

Positive
  • Dual listing on NYSE Texas could broaden investor reach and enhance share liquidity without diluting existing shareholders.
Negative
  • None.

Insights

TL;DR: Dual listing may improve liquidity and visibility but is not a transformative financial event.

The additional NYSE Texas listing offers UAMY shareholders an alternative trading venue, potentially tightening bid-ask spreads and expanding the investor base. Because the Company maintains its NYSE American listing and no capital raise is attached, the move is largely administrative. Market impact will depend on NYSE Texas’ trading volume and market-maker participation. Absent new financial data or strategic initiatives, the event is modestly positive but not materially transformative for valuation.

United States Antimony Corporation (NYSE American: UAMY) ha ottenuto una quotazione secondaria sulla neocostituita NYSE Texas Exchange. Il 27 giugno 2025, la Borsa ha approvato formalmente la domanda della Società e la negoziazione delle azioni UAMY su NYSE Texas è prevista per martedì 1 luglio 2025. La Società manterrà la sua quotazione primaria su NYSE American e continuerà a essere negoziata con il simbolo “UAMY” su entrambe le piattaforme. Un comunicato stampa che annuncia la doppia quotazione è allegato come Exhibit 99.1 e integrato in questo modulo 8-K/A sotto la voce 8.01. Non sono state divulgate altre informazioni operative o finanziarie; la documentazione è fornita e non depositata ai fini della responsabilità ai sensi dell'Exchange Act.

United States Antimony Corporation (NYSE American: UAMY) ha asegurado una cotización secundaria en la recién creada Bolsa NYSE Texas Exchange. El 27 de junio de 2025, la Bolsa aprobó formalmente la solicitud de la Compañía y se espera que la negociación de las acciones UAMY en NYSE Texas comience el martes 1 de julio de 2025. La Compañía mantendrá su cotización primaria en NYSE American y continuará operando bajo el símbolo “UAMY” en ambos mercados. Un comunicado de prensa que anuncia la doble cotización se presenta como Exhibit 99.1 e incorporado en este Formulario 8-K/A bajo el ítem 8.01. No se divulgaron otras informaciones operativas ni financieras; la presentación se proporciona y no se registra para fines de responsabilidad bajo la Exchange Act.

United States Antimony Corporation (NYSE American: UAMY)는 새로 설립된 NYSE Texas Exchange에 2차 상장을 확보했습니다. 2025년 6월 27일, 거래소는 회사의 신청을 공식 승인했으며, UAMY 주식의 NYSE Texas 거래는 2025년 7월 1일 화요일에 시작될 예정입니다. 회사는 NYSE American에서의 주 상장을 유지하며 두 거래소 모두에서 “UAMY” 티커로 계속 거래될 것입니다. 이중 상장을 알리는 보도자료는 Exhibit 99.1로 제출되어 본 8-K/A 양식의 항목 8.01에 통합되어 있습니다. 추가적인 운영 또는 재무 정보는 공개되지 않았으며, 이 제출은 Exchange Act 책임 목적을 위한 제공(furnished)이며 제출(filed)은 아닙니다.

United States Antimony Corporation (NYSE American : UAMY) a obtenu une cotation secondaire sur la nouvelle Bourse NYSE Texas Exchange. Le 27 juin 2025, la Bourse a officiellement approuvé la demande de la Société, et la négociation des actions UAMY sur NYSE Texas devrait débuter le mardi 1er juillet 2025. La Société conservera sa cotation principale sur NYSE American et continuera à être négociée sous le symbole « UAMY » sur les deux places. Un communiqué de presse annonçant la double cotation est déposé en tant qu’Exhibit 99.1 et intégré à ce formulaire 8-K/A sous l’Item 8.01. Aucune autre information opérationnelle ou financière n’a été divulguée, et ce dépôt est fourni (furnished) — non déposé (filed) — aux fins de responsabilité au titre de l’Exchange Act.

United States Antimony Corporation (NYSE American: UAMY) hat eine Zweitnotierung an der neu gegründeten NYSE Texas Exchange erhalten. Am 27. Juni 2025 genehmigte die Börse offiziell den Antrag des Unternehmens, und der Handel mit UAMY-Aktien an der NYSE Texas soll am Dienstag, den 1. Juli 2025 beginnen. Das Unternehmen behält seine Hauptnotierung an der NYSE American bei und wird unter dem Tickersymbol „UAMY“ an beiden Börsen gehandelt. Eine Pressemitteilung zur Bekanntgabe der Doppelnotierung ist als Exhibit 99.1 eingereicht und in dieses Formular 8-K/A unter Punkt 8.01 aufgenommen. Weitere operative oder finanzielle Informationen wurden nicht offengelegt; die Einreichung erfolgt zur Haftungszwecken gemäß Exchange Act als „furnished“, nicht als „filed“.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KING MARY JANE

(Last) (First) (Middle)
C/O ENTERPRISE BANK
222 MERRIMACK ST

(Street)
LOWELL MA 01852

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ENTERPRISE BANCORP INC /MA/ [ EBTC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/01/2025 D 15,309 D (1) 0(2) D
Common Stock 07/01/2025 D 2,500 D (1) 0 I By Husband
Common Stock 07/01/2025 D 2,200 D (1) 0 I By King Family Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Pursuant to the Agreement and Plan of Merger, dated as of December 8, 2024 (the "Merger Agreement"), by and among Enterprise Bancorp, Inc. ("Enterprise"), Enterprise Bank and Trust Company, Independent Bank Corp. ("Independent") and Rockland Trust Company, each issued and outstanding share of Enterprise common stock was converted into the right to receive (i) $2.00 in cash and (ii) 0.60 shares of Independent common stock (subject to the payment of cash in lieu of fractional shares).
2. In accordance with the Merger Agreement, all unvested shares of restricted stock automatically vested in full at the Effective Time (as defined in the Merger Agreement) to the extent not previously forfeited, and was considered outstanding shares of Enterprise common entitled to receive the Merger Consideration (as defined in the Merger Agreement).
/s/ Joseph R. Lussier as attorney-in-fact for Mary Jane King 07/01/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

When will UAMY start trading on NYSE Texas?

Trading is expected to commence on Tuesday, July 1, 2025.

Will United States Antimony Corporation change its ticker symbol?

No. The Company will continue to trade under the ticker “UAMY” on both NYSE American and NYSE Texas.

Does the dual listing involve a share offering or dilution?

The filing discloses no new share issuance; the listing is administrative only.

Is NYSE American still the primary listing for UAMY?

Yes. The Company will maintain its primary listing on NYSE American while also trading on NYSE Texas.

Where can I read the official press release about the dual listing?

The press release is filed as Exhibit 99.1 to this Form 8-K/A.
Enterprise Bancorp Inc Mass

NASDAQ:EBTC

EBTC Rankings

EBTC Latest News

EBTC Latest SEC Filings

EBTC Stock Data

487.70M
9.85M
20.71%
34.07%
0.77%
Banks - Regional
State Commercial Banks
Link
United States
LOWELL